Quest Diagnostics Inc
NYSE:DGX

Watchlist Manager
Quest Diagnostics Inc Logo
Quest Diagnostics Inc
NYSE:DGX
Watchlist
Price: 152.63 USD -0.25% Market Closed
Market Cap: 17B USD
Have any thoughts about
Quest Diagnostics Inc?
Write Note

Quest Diagnostics Inc
Cash Interest Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Quest Diagnostics Inc
Cash Interest Paid Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Interest Paid CAGR 3Y CAGR 5Y CAGR 10Y
Quest Diagnostics Inc
NYSE:DGX
Cash Interest Paid
$204m
CAGR 3-Years
5%
CAGR 5-Years
0%
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CVS Health Corp
NYSE:CVS
Cash Interest Paid
-$2.8B
CAGR 3-Years
-4%
CAGR 5-Years
6%
CAGR 10-Years
-16%
Cigna Corp
NYSE:CI
Cash Interest Paid
$1.3B
CAGR 3-Years
2%
CAGR 5-Years
0%
CAGR 10-Years
5%
Laboratory Corporation of America Holdings
NYSE:LH
Cash Interest Paid
$220.2m
CAGR 3-Years
5%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
R1 RCM Inc
NASDAQ:RCM
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Quest Diagnostics Inc
Glance View

Market Cap
17.1B USD
Industry
Health Care
Economic Moat
None

In the rapidly evolving world of healthcare, Quest Diagnostics Inc. stands as a pivotal player, shaping the future of diagnostic services. Born out of a quest for innovation in clinical testing, Quest Diagnostics operates at the intersection of medical science and cutting-edge technology. The company has a wide-reaching network of laboratories and service centers, offering a comprehensive array of diagnostic testing solutions that range from routine blood tests to advanced genetic screening. Their services are not limited to hospitals and physician offices; they extend into a variety of sectors including pharmaceuticals, food, and global business services, completing over a hundred million clinical laboratory tests annually. Quest's robust infrastructure and commitment to precision ensure that patients and healthcare providers receive timely and accurate information that is crucial for early detection, diagnosis, and informed treatment decisions. Quest Diagnostics' revenue model is straightforward yet effective, driven primarily by service fees from its expansive menu of tests. By collaborating with insurers, healthcare providers, and employers, Quest ensures broad access to its services. Moreover, the company continually invests in research and development to expand its test portfolio and enhance the quality of its services, thus staying competitive in the fast-paced healthcare environment. Through strategic acquisitions and partnerships, Quest has broadened its geographical reach and bolstered its technological capabilities, maintaining its position as an industry leader. As healthcare increasingly leans toward personalized medicine and preventive care, Quest Diagnostics is poised to leverage its analytical prowess and deep repository of health data to drive future growth and innovation, serving as an indispensable ally in global public health.

DGX Intrinsic Value
150.73 USD
Overvaluation 1%
Intrinsic Value
Price

See Also

What is Quest Diagnostics Inc's Cash Interest Paid?
Cash Interest Paid
204m USD

Based on the financial report for Sep 30, 2024, Quest Diagnostics Inc's Cash Interest Paid amounts to 204m USD.

What is Quest Diagnostics Inc's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 5Y
0%

Over the last year, the Cash Interest Paid growth was 43%. The average annual Cash Interest Paid growth rates for Quest Diagnostics Inc have been 5% over the past three years .

Back to Top